• Startseite
• generic
• Mylan's Generic EpiPen — A Price Break Or Marketing Maneuver

Mylan's Generic EpiPen — A Price Break Or Marketing Maneuver

4.6 (686) · € 22.00 · Auf Lager

Under fire, Mylan to offer generic EpiPen for 50% less

Correction: Mylan-Pfizer story

EpiPen: Facts Vs. Opinion; With Cost-Benefit Analysis (NASDAQ:VTRS)

pharmaceuticals The Lund Report

Mylan's Generic EpiPen — A Price Break Or Marketing, 51% OFF

What if EpiPen price hikes were designed to crush rivals? Sanofi suit claims that, and much more

EpiPen: Out of Reach - Ethics Unwrapped

Mylan Launches the First Generic for EpiPen® (epinephrine injection, USP) Auto-Injector as an Authorized Generic

Mylan's Generic EpiPen – A Price Break or Marketing Maneuver?